• N/A
    Market Cap
  • -98.77%
    1-Year Change
  • Pharmaceutical Retailers
    Industry
Annual
Quarterly
03/31/2025
03/31/2024
03/31/2023
03/31/2022
Income Statement
Total Operating Revenue
120.0M
-22.37%
154.5M
+3.85%
148.8M
-9.48%
164.4M
N/A
Cost of Revenue
116.1M
-5.91%
123.4M
+7.77%
114.5M
-10.43%
127.9M
N/A
Gross Profit
3.8M
-87.66%
31.1M
-9.25%
34.3M
-6.13%
36.5M
N/A
Sales and Marketing Expense
1.5M
-94.40%
27.4M
-6.14%
29.2M
-5.51%
30.9M
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
1.1M
+43.87%
790,449
+10.09%
718,002
-42.86%
1.3M
N/A
Total Operating Expenses
4.9M
-85.93%
34.6M
-37.25%
55.2M
+40.78%
39.2M
N/A
Operating Profit
-1.0M
-70.71%
-3.5M
-83.11%
-20.9M
+676.77%
-2.7M
N/A
Interest Income
N/A
N/A
-1.6M
-30.62%
-2.3M
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
-262,218
N/A
Interest Income and Expense and Net
0
+100.00%
-1.6M
-30.62%
-2.3M
+783.61%
-262,218
N/A
Total Nonoperating Income and Expense
-8,155
-101.74%
467,687
-72.16%
1.7M
+268.81%
455,547
N/A
Income before Taxes
-950,660
-77.21%
-4.2M
-79.89%
-20.7M
+888.46%
-2.1M
N/A
Income Taxes
503,524
+701.00%
62,862
-84.07%
394,541
-64.12%
1.1M
N/A
Extraordinary Items
0
N/A
N/A
N/A
148,795
0.00%
148,795
N/A
Net Income
10.2M
+340.76%
-4.2M
-79.97%
-21.1M
+562.21%
-3.2M
N/A
Net Income from Continuing Operations Applicable to Common
-950,660
-77.21%
-4.2M
-79.89%
-20.7M
+888.46%
-2.1M
N/A
Basic EPS and Net Income
1.84
+162.80%
-2.93
+41.55%
-2.07
+125.00%
-0.92
N/A
Diluted EPS and Net Income
1.84
+162.80%
-2.93
+41.55%
-2.07
+125.00%
-0.92
N/A
Basic Weighted Average Shares
5.5M
+283.80%
1.4M
-85.84%
10.2M
+193.06%
3.5M
N/A
Diluted Weighted Average Shares
5.5M
+283.80%
1.4M
-85.84%
10.2M
+193.06%
3.5M
N/A
Balance Sheet
Cash and Cash Equivalents
12.8M
-36.58%
20.1M
+7.13%
18.8M
+1.89%
18.5M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
12.8M
-36.58%
20.1M
+7.13%
18.8M
+1.89%
18.5M
N/A
Total Current Assets
59.7M
-14.31%
69.7M
+8.06%
64.5M
-14.54%
75.5M
N/A
Accumulated Depreciation
82,664
-99.20%
10.4M
+0.87%
10.3M
-39.22%
16.9M
N/A
Property and Plant and Equipment and Net
8,931
-99.82%
4.9M
-3.80%
5.1M
-13.88%
5.9M
N/A
Total Long-Term Assets
4.8M
-81.18%
25.4M
-4.20%
26.5M
+3,118.64%
822,950
N/A
Total Assets
64.5M
-32.16%
95.1M
+4.49%
91.0M
-14.49%
106.4M
N/A
Income Taxes Payable
2.0M
+195.16%
682,239
-60.03%
1.7M
+23.59%
1.4M
N/A
Total Short-Term Debt
10.4M
-67.49%
32.0M
+9.22%
29.3M
-19.06%
36.1M
N/A
Total Current Liabilities
34.4M
-53.80%
74.4M
+11.76%
66.5M
-10.63%
74.4M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
29.3M
-19.06%
36.1M
N/A
Total Long-Term Liabilities
492,121
-92.32%
6.4M
-17.56%
7.8M
-15.54%
9.2M
N/A
Total Liabilities
34.8M
-56.85%
80.8M
+8.69%
74.3M
-11.17%
83.6M
N/A
Retained Earnings
-63.3M
-13.87%
-73.5M
+6.11%
-69.3M
+43.92%
-48.1M
N/A
Total Stockholders Equity
29.6M
+89.49%
15.6M
-13.18%
18.0M
-25.21%
24.1M
N/A
Total Shares Outstanding
5.9M
+235.85%
1.7M
-92.64%
23.7M
+581.09%
3.5M
N/A
Cash Flow
Cash from Operating Activities
1.2M
+139.54%
-3.2M
-3.90%
-3.3M
-39.04%
-5.4M
N/A
Capital Expenditures
155,360
-53.02%
330,677
+179.59%
118,272
+31.47%
89,960
N/A
Cash from Investing Activities
-18.1M
+789.04%
-2.0M
+545.32%
-316,097
+3.25%
-306,138
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
1.5M
-81.19%
8.0M
+238.28%
2.4M
-51.08%
4.8M
N/A
Financials Ratio
Gross Margin
3.20%
-84.10%
20.13%
-12.62%
23.04%
N/A
N/A
N/A
Operating Margin
-0.86%
-62.27%
-2.29%
-83.74%
-14.06%
N/A
N/A
N/A
Return on Assets
12.78%
+380.73%
-4.55%
-78.75%
-21.42%
N/A
N/A
N/A
Return on Equity
45.03%
+278.96%
-25.16%
-74.94%
-100.42%
N/A
N/A
N/A
Revenue Growth
-22.37%
-681.03%
3.85%
+140.62%
-9.48%
N/A
N/A
N/A
Current Ratio
1.74
+85.46%
0.94
-3.31%
0.97
N/A
N/A
N/A
Cash Ratio
0.37
+37.27%
0.27
-4.14%
0.28
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
3.25
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
0.64
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow